🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Xylem shares hold as RBC maintains price target, Outperform rating

EditorAhmed Abdulazez Abdulkadir
Published 05/31/2024, 08:46 PM
XYL
-

On Friday, RBC Capital maintained its Outperform rating and a $162.00 price target for shares of Xylem (NYSE:XYL). During an analyst event on May 30, Xylem unveiled the new leadership team's priorities, which are set to optimize the company's portfolio. The event marked the beginning of what RBC Capital refers to as Xylem's "Portfolio Optimization Era."

The company's leadership outlined a strategy for growth and profitability, including an ambitious goal for annual margin improvement. Xylem aims to improve margins by 100 basis points annually from 2024 to 2027, which is notably higher than the previously anticipated 50-75 basis points.

The strategy includes the implementation of 80/20 and simplification actions, which involve streamlining operations and shedding unprofitable legacy customers and products. RBC Capital highlighted this approach as a significant step in Xylem's growth trajectory.

Additionally, the company identified PFAS remediation as a potential growth area, although the financial impact of this initiative has not yet been quantified. PFAS, or per- and polyfluoroalkyl substances, are a group of chemicals that have come under scrutiny for their environmental and health impacts, and remediation efforts represent a growing market.

InvestingPro Insights

In light of RBC Capital's positive outlook on Xylem, current data from InvestingPro provides additional context for investors considering the company. With a market capitalization of $33.8 billion and a high P/E ratio of 48.98, reflecting investor expectations of future growth, Xylem's financial health appears robust. The company's revenue growth is noteworthy, with a 39.51% increase over the last twelve months as of Q1 2024, and a quarterly revenue growth of 40.4% in Q1 2024. This impressive growth trajectory aligns with the strategic initiatives highlighted by RBC Capital.

InvestingPro Tips further enrich the outlook on Xylem with the information that the company has raised its dividend for 13 consecutive years and that analysts are revising their earnings upwards for the upcoming period. Such consistent dividend growth, coupled with a 9.09% increase in dividend growth over the last twelve months as of Q1 2024, signals a strong commitment to shareholder returns. Additionally, the company's stock is known for low price volatility, which might appeal to investors seeking stability.

For investors seeking more detailed analysis and additional InvestingPro Tips for Xylem, they can explore further insights on InvestingPro. There are over 14 additional tips available, offering a comprehensive understanding of Xylem's financial health and market position. To enhance your investment strategy, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.